Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Altamira Therapeutics Ltd (NASDAQ: CYTO) closed at $0.43 up 3.71% from its previous closing price of $0.41. In other words, the price has increased by $3.71 from its previous closing price. On the day, 0.99 million shares were traded. CYTO stock price reached its highest trading level at $0.62 during the session, while it also had its lowest trading level at $0.41.
Ratios:
For a deeper understanding of Altamira Therapeutics Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.43 and its Current Ratio is at 0.43. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYTO now has a Market Capitalization of 1624763 and an Enterprise Value of 1510307.
Stock Price History:
Over the past 52 weeks, CYTO has reached a high of $17.20, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -30.76%, while the 200-Day Moving Average is calculated to be -66.14%.
Shares Statistics:
For the past three months, CYTO has traded an average of 362.40K shares per day and 44950 over the past ten days. A total of 3.78M shares are outstanding, with a floating share count of 3.76M. Insiders hold about 0.53% of the company’s shares, while institutions hold 0.07% stake in the company. Shares short for CYTO as of 1730332800 were 31093 with a Short Ratio of 0.09, compared to 1727654400 on 23592. Therefore, it implies a Short% of Shares Outstanding of 31093 and a Short% of Float of 0.83.
